Marizyme, Inc. Appoints Veteran Business Executive Julie Kampf to Board

Written by user2 on . Posted in JBK Media

JUPITER, Fla., Feb. 4, 2021 /PRNewswire/ -- Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that it has named veteran business executive Julie Kampf as an Independent Member of its Board of Directors.

JBK Video Gallery

Written by JBK Administrator on . Posted in JBK Media

The JBK video gallery provides our clients with a glimpse into how our company compares to others. See how our diverse team of innovative thinkers has impacted the world today and brings companies and leaders together.

"Connecting great leaders to great companies... Advancing the world together!"